Advisors Capital Management LLC Acquires New Stake in GE HealthCare Technologies Inc. $GEHC

Advisors Capital Management LLC purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 11,187 shares of the company’s stock, valued at approximately $840,000.

Several other large investors have also recently modified their holdings of the business. Allianz SE grew its stake in GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after buying an additional 218 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. grew its position in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares in the last quarter. Godsey & Gibb Inc. bought a new stake in shares of GE HealthCare Technologies during the 3rd quarter valued at $26,000. Oakworth Capital Inc. lifted its holdings in GE HealthCare Technologies by 1,876.2% during the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after purchasing an additional 394 shares in the last quarter. Finally, Piscataqua Savings Bank boosted its stake in GE HealthCare Technologies by 173.4% in the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after purchasing an additional 300 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on GEHC shares. Wells Fargo & Company boosted their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Jefferies Financial Group lifted their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price objective for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Piper Sandler boosted their price target on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. Finally, BTIG Research raised their price objective on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Hold” and an average price target of $92.50.

GE HealthCare Technologies Stock Up 0.1%

Shares of GEHC stock opened at $83.01 on Friday. The stock’s fifty day moving average price is $82.26 and its 200 day moving average price is $77.88. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $93.14. The company has a market cap of $37.83 billion, a price-to-earnings ratio of 18.20, a price-to-earnings-growth ratio of 1.83 and a beta of 1.08. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. GE HealthCare Technologies’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.